Sentence: Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine : a multicenter , phase II trial of the Swiss Group for Clinical Cancer Research .
Drug combination annotation:
[{'class': 'POS', 'spans': ['gemcitabine', 'capecitabine'], 'is_context_needed': True}]